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Many surgical metals such as stainless steel, titanium, magnesium and its alloys have been extensively used for the 
recovery of body structures in human beings. Corrosion is the major reason for failure in metallic implants, when the metal 
comes in contact with the body fluids it releases metal ions into the surrounding tissues. This may even lead to the second 
surgery which can be eradicated by the surface modification of the implant with bioceramics using coating techniques. The 
present work involves the development of coatings on the surface of 316L SS type of stainless steel using a biphasic mixture 
of bio ceramics HAP/β-TCP in ratio of 7.5:2.5 by electrophoretic deposition (EPD) from a suspension of ethanol. The 
presence of biphasic coating imparts the property of both bioactivity and bioresorbability to the implant with good 
adherence of the coatings in body fluids. These coatings provide corrosion resistance and also favour new bone growth. 
Further, the biocompatibility of these materials can be evaluated by in-vitro assay. This includes cytotoxicity tests carried 
out with normal cell line (Vero cell line) and cancerous cell line (HEP II cell Line). The coated samples have been tested for 
their biochemical nature using DPPH (2,2 diphenyl 1 picryl hydrazil compound) activity to confirm whether the coated 
implant is suitable for cancerous patients with its antioxidant property which helps to trap the free radicals. 
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One of the most rewarding aspects of material science 
is the use of the biomaterials to alleviate a person 
suffering from fractures and damages in bone tissues. 
The advanced development of material science led to 
the use of surgical grade biomaterials as the materials 
for implant. Biomaterials are generally synthesized by 
using several chemical methods in laboratories or 
extracting them from the natural sources1. These 
synthetic materials can be replaced in the body tissues 
and organs after they are proven to be biocompatible. 
Metallic implants such as stainless steels, titanium 
and magnesium alloys used as orthopedic prostheses 
provides improved mechanical features that matches 
with the anatomical structure and functions of the 
bone. The biocompatibility and corrosion resistance 
of these implants are primarily determined by their 
constituent material and surface micro structural 
properties such as surface roughness, grain size, etc.2. 
Type 316L SS are traditionally used for implantation 
purposes in orthopaedic surgery owing to their 
general corrosion resistance, mechanical properties 
and low cost3,4.
To overcome the problem of corrosion, the 
implants can be coated with bio ceramics. Based on 
the nature of bioceramics the biological properties 
keep changing. The functions of an implant may be 
modified to be bioactive with the hydroxyapatite 
coated implants and bioresorbable with the tri calcium 
phosphate coated implants5. HAP is present naturally 
in bones, however, it cannot be directly used for 
making implant devices because of its brittleness and 
strength limitations, while β-TCP with its 
bioresorbable property stimulates new bone 
deposition. Hence, a great deal of research 
concentrates on the development of HAP/β-TCP as 
coating and composites6. 
The biocompatibility of implant or matrix for a 
tissue-engineering product refers to the ability to 




perform as a substrate that will support the 
appropriate cellular activity. After implantation it 
includes molecular and signalling role inside the 
system in order to optimize tissue regeneration, 
without provoking undesirable effects in those cells7-11. 
The selection of HAP and β-TCP bio ceramics is 
considered to be best as they show similarity with 
minerals in natural bone and are widely used in hard 
tissue repair and report supports that they can form a 
protective layer as both are biocompatible12,13. These 
materials on implantation at osseous site, provides an 
ideal environment for cellular reaction and leads to 
osteoconduction which induces bone growth, bonds to 
implant and promotes a functional interface14. 
Identifying the reliable coating process is another 
important key factor, since it provides protection to a 
specific structure exposed to different environment 
which surrounds the implant inside the human body15. 
In this research work synthesized hydroxyapatite 
(HAP)/ β-Tricalcium phosphate (β-TCP) powders in 
the ratio of 7.5:2.5 (i.e. 0.75mg HAP mixed with 
0.25mg β-TCP) have been prepared. HAP/ β-TCP has 
been chosen because of bioactive character of HAP 
and bioresorbable character and the phosphate groups 
of β-TCP which acts as coupling/anchoring agent, it is 
a good cation absorber and has higher affinity towards 
the HAP particles and enables new bone 
formation16,17. HAP concentration should be more 
when compared to β-TCP. These materials have been 
made into a suspension with ethanol and 
electrophoretically deposited over 316L SS cathode. 
In-vitro analysis of the coated samples has been 
carried using MTT assay to assess the 
biocompatibility with both normal and cancerous 
cells. Further, these materials have been tested for the 
DPPH activity to confirm whether the materials can 
be used as one of the components for the bone tissue 
scaffolds18,19. The extensive study has been carried out 
using in-vitro biocompatibility and the cell 
proliferation in the synthesized HAP/β-TCP mixture. 
Figure 1 shows the schematic representation of EPD 




Calcium nitrate tetrahydrate AR (Ca (NO3)2.4H2O), 
diammonium hydrogen phosphate AR (NH4)2HPO4, 
concentrated ammonia (NH3), cetyl trimethyl 
ammonium bromide, (CTAB) were purchased from 
Sisco Research Laboratories (SRL) Ltd., India and  
all other chemicals were used further without 
purification. Type 316L SS was used as the substrate 
 
 
Fig. 1 — Schematic representation of EPD deposited biphasic HAP/ β-TCP coatings and their biocompatibility evaluation. 
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for coating HAP/β-TCP. The elemental composition 
of the alloy using direct reading emission 
spectrometer (Jobin-Yvon, Paris) was given as 
C- 0.029, Mn-1.8,Cr-17.3, Ni-12.4, Si-.0.7, Mo-2.25,
P-0.031, S -0.012.
Sample preparation 
Surface condition of the alloy plays a major role in 
the development of HAP coating. Type 316L SS alloy 
is taken in annealed condition was cut into 
10 × 10 × 2 mm size pieces for experimental use. The 
edges of the specimens were polished up to 1000 grit 
SiC paper to bring it to uniform surface condition. 
The test specimen was attached to a threaded brass 
rod using silver paste in between the brass rod and the 
specimens to get the proper electrical contact. The 
samples were molded using an epoxy resin (Araldite, 
Ciba Geigy) in case of the uncoated type 316L SS 
sample.  
HAP/β-TCP was synthesized in the laboratory 
following established procedures in the lab from 
literature17. The purity was checked by analyzing the 
chemical composition using titrimetric for calcium 
and phosphate spectrophotometrically. The crystalline 
structure was further confirmed by XRD.  
The stoichiometric HAP powder synthesized with 
Ca/P ratio of 1.67 was used as the starting material. 
The powders were ground finely with a mortar and 
pestle and sieved with ASTM sieve no.500. The 
stoichiometric TCP powder was synthesized and the 
β form of TCP was used for the experiment. The 
coatings were developed by electrophoretic deposition 
(EPD) at room temperature from 2% suspension of 
HAP/β-TCP in the ratio of 7.5:2.5, in ethanol taken in 
a 100 mL glass beaker, closed with teflon covering. 
Magnetic stirring was used to keep the particles in 
suspension. AISI type 316L SS samples were 
mechanically polished using grit SiC papers from 120 
to 600. The electrodes were washed thoroughly with 
running distilled water, rinsed, degreased with ethanol 
and dried. The 304 SS sheet was used as anode while 
the polished sample can be used as a cathode20. Both 
these electrodes were immersed in the suspension. 
The coatings were obtained at 10V, 15V, 20V, 25V 
and 30V for various time durations. The substrate, 
316L SS was weighed before and after the deposition. 
Triplicate sample coatings were done for each 
parameter21. The coated samples were sintered for 1 h 
in furnace at 600oC. The coatings were further 
characterized to study their properties using XRD and 
FTIR. MTT assay was used to study the 
biocompatibility, were cells in the exponential phase 
of growth are when exposed to toxicity. The 
crystalline nature of the HAP/TCP powders and 
coated type 316L SS were studied with (XRD, model: 
Rich–Seifert, 2000D) using Ni filtered Cu Kα 
radiation at 30 kV and 20 mA. The 2θ angles were 
swept from 20 to 65° in steps of one degree. The 
functional characteristics of HAP/TCP powders were 
characterized with Perkin-Elmer FTIR Paragan series 
instrument. The spectra of the powders were recorded 
in the form of KBr (spectroscopic grade) pellet from 
4000 - 490 cm-1 wave number with a resolution of 4 
cm-1. The images were recorded using Canon Power
Shot SX530 Digital Camera.
The exposure duration of the cells were determined 
by the stability of the implant and also by the time 
required for the maximum damage. The number of 
surviving cells was then determined by the MTT dye 
reduction which is a soluble tetrazolium salt that would 
be converted into insoluble formazan precipitate by 
viable (mitochondrial reductase) enzymes in the cell. 
The MTT formazan can be dissolved in a suitable 
solvent to get a MTT formazon precipitate. 
The precipitate thus formed can be determined 
spectrophotometrically. Cell viability studies were 
carried out on the coated samples by suspending the 
cells again in growth medium (RPMI 1640 medium with 
10% fetal bovine serum) and were observed. The cell 
suspension was diluted with growth medium to get 2.5-
5.08 ×103 cells and allowing cell suspension of about 20 
mL per micro titration plate. Diluted cell suspensions 
were transferred to a 9 cm petri dish and 200µL of cell 
suspensions was transferred into each well of the central 
10 columns of a flat bottomed 96 well plate using 
multichannel micropipette. 200µL of growth medium 
was added to the eight wells in the column22 1&12. The 
micro titration plate was covered with its lid & incubated 
in a humidified atmosphere for the biomaterials (HAP/β-
TCP mixture). A several fivefold dilutions of the 
materials (HAP/β-TCP) in growth medium were 
prepared to give eight concentrations. Cells in eight 
wells of column 2 and 11 were added with 200 mL of 
fresh medium and these columns were used as control. 
200 µL of samples was transferred to the wells in 
columns 3 to 10 using micropipette. Plates were covered 
with its lid and incubated for a definite exposure period. 
The mixture was removed from all the wells containing 
cells at the end of its exposure period and the cells were 
fed with 200 µL of fresh medium. The plates were fed 
daily for 2-3 PDTs (Population doubling time)23. 




DPPH (2,2 diphenyl 1 picryl hydrazil) assay was 
carried out to study the antioxidant property which is 
considered as one of the health protecting factor. This 
method involved the use of free radical 2,2 diphenyl 1 
picryl hydrazil (DPPH). The odd or unpaired electron 
in the DPPH free radical gave a strong adsorption 
maximum at 517 nm and was purple in colour. This 
was turned to yellow due to the reduction of DPPH 
radical to DPPH-H due to the scavenging activity of 
free radicals. 
 
Results and Discussion 
Electrophoretic deposition  
EPD of HAP/β-TCP over 316L SS were carried out 
to optimize the time and voltage of the coatings. The 
desired time was calculated when the coatings were 
carried out based on the physical nature of the coatings 
and this was found to be better at a constant voltage of 
20 V. After several assessments the good and adherent 
coat of HAP/β-TCP over 316L SS was found at 20 min 
of coating time duration. Similarly, at a constant time 
of 20 minutes, the different voltages were analyzed to 
get the maximum coating weight gain. The data 
presented in Table 1 suggest that the maximum weight 
gain obtained at 20 min of time when compared to 15, 
10, 25 and 30 minutes, respectively. Table 2 indicates 
that the maximum weight gain obtained at 20V when 
compared to 15, 10, 25 and 30V, respectively. After 
optimizing the voltage and time, 20V and 20 minutes 
were considered as the desired voltage and time to 
obtain a good adherent coating and the EPD after 
evaluating the coatings on each substrate with 5 times. 
Figure 2 shows the images of the coated sample 
obtained at 20V, 20min on 316L SS after sintering 
using Canon Power Shot SX530 Digital Camera. The 
image obtained shows that uniform coatings were 
formed on the cathode 316L SS which were strongly 
adhered to the substrate even after sintering. The above 
image confirms the formation of uniform coatings of 
the biphasic material HAP/β-TCP on 316L SS after 
sintering. The images indicate the absence of base 
metal oxides on the surface of the coatings indicating 





X-Ray diffraction studies in Fig. 3 (a, b & c) shows 
the patterns of HAP, β-TCP and HAP/β-TCP 
composites, respectively which represent that the 
HAP and β-TCP exists together in the prepared 
composite. The peaks such as (002), (121), (300), 
(222), (310), (321), (305), (502), were attributed to 
the crystalline nature of the HAP and was matched 
with the JCPDS file no.09-0432. These patterns 
suggest that there is no structural transformation of 
HAP after sintering. The peaks obtained for β-TCP 
are (221), (110), (200), (311), (220), (433) and were 
matched according to the JCPDS file no 09-1069. 
 
FTIR spectroscopy analysis 
Fourier transform infrared spectroscopy is used to 
determine the different functional groups present in 
the coated sample. The spectrum was recorded in the 
range of 4000-490 cm-1. Figure 4 shows the FTIR 
pattern of (a) HAP, (b) β-TCP and (c) HAP/β-TCP on 
316L SS obtained at 20V, 20 minutes after sintering. 
Theoretically, there are four vibration  modes  present  
 
 
Fig. 2 — Images of the coated sample obtained at 20V, 20min on
316 LSS after sintering. 
Table 1 — Variation in weight of HAP/ β-TCP with changes in 







1 20 mins 1.3 
2 15 mins 0.9 
3 10 mins 0.4 
4 25 mins 1.1 
5 30 mins 0.8 
 
 
Table 2 — Change in weight of HAP/ β-TCP with change in 






1 20 V 1.5 
2 15 V 0.9 
3 10 V 0.4 
4 25 V 1.0 
5 30 V 0.5 
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Fig. 3 — XRD pattern of (a) HAP, (b) β-TCP and (c) HAP/β-TCP 
on 316 LSS obtained at 20V, 20 minutes after sintering. 
in phosphate ion ν1, ν2, ν3 and ν4. The ν1 and ν3 
phosphate bands in the 900-1200 cm-1 and ν4 
absorption bands in the region 500-700 cm-1 are used 
to characterize the structure of apatite. The strong 
sharp peaks represent the symmetric and asymmetric 
stretching mode of vibration for PO4
3- group. 
Specifically, the peak obtained between the range of 
510-610 cm-1 and 1010-1094 cm-1 corresponds to the
ν4 and ν3 modes of phosphates ions, respectively. The
peak at 1420cm-1 corresponds to the presence of
carbonate group (CO3
2-). The peak at 3390 cm-1 
represents the presence of O-H stretching vibrations.
Biocompatibility assay 
A cell line of normal cell (Vero cells) and the 
cancerous cell (HEP II cells) obtained from NCCS, 
Pune, India was used for the MTT assay. 
Cell viability and biocompatibility studies using vero cells 
The percentage of cell viability in normal vero cell 
is given in the Table 3. These results show that 30% 
cells are viable at the concentration of 5 μg and EPD 
coatings coated over the sample alone can interact 
with the cells. This indicates good compatibility of the 
coatings. Figure 5 shows the cell cytotoxicity dose for 
HAP/β-TCP on 316L SS at 20V, 20 minutes after 
sintering- Normal cells (CCD: CCD 50 =1.6µg). 
Hence, the study suggests that more than 50% 
viability can be seen while using the coated material 
as an implant device in normal cells.   
Figure 6 shows cell viability in vero cells 
(A) normal vero cell line (B) 50% cell viability with
Fig. 4 — FTIR pattern of (a) HAP, (b) β-TCP and (c) HAP/β-TCP 
on 316 LSS obtained at 20V, 20 minutes after sintering. 




biphasic HAP/ β-TCP coated samples under Light 
microscopy. 30% of the coating weight was 
calculated at different potentials and it was 
standardized to a coat value of 0.01 µg and this 
indicates that these biphasic materials are not toxic to 
the cells. The material biocompatibility data are 
presented in Table 3. Normally, 50% of cells are 
viable, which indicates that the materials show a good 
biocompatibility with the particular cell line. Hence, 
from the standardization procedure one can confirm 
whether a particular material is not toxic to the 
particular cell line. 
The biphasic coatings obtained by electrophoretic 
deposition; the maximum amount of the material 
distribution occurs over the metal was found to be 
0.454 µg. IC 50 value represents when the viability is 
50% which indicates the concentration corresponding 
to the 50% viability. It is an accepted concentration 
used as an implant. In the present work the 50% 
viability corresponds to the 1.6μg /mL and this is very 
much high when compared to the concentration of 
material coated over the substrate. For the samples 
with maximum coating weight of about 0.454 µg 
shows more than 90% viability and this confirms that 
the materials after coating and sintering shows good 
biocompatibility. 
 
Cell viability of HEP II cells 
The changes in percentage (%) of cell viability of 
HEP II-Cells with changes in biphasic HAP/ β-TCP 
coatings are given in Table 4. The analysis shows 
27% cells were viable at the concentration of 5 µg. It 
was suggested that the weight corresponding to 50% 
viability shows good compatibility for that particular 
size. Figure 7 shows the cell cytotoxicity dose for 
HAP/β-TCP on 316L SS at 20V, 20 min after 
sintering- Cancerous cells (CCD: CCD 50 =0.4µg). 
When the substrate is subjected to EPD for 20 
minutes duration at 20V maximum weight gain of 
0.454 µg is obtained, which is more than 0.4 µg. 
Figure 8 shows the cell viability in HEP II CELLS 
(A) HEP II cells in addition of HAP/ β-TCP under 
light microscopy (B) HEP II cells after addition of 
HAP/ β-TCP with 50% cell viability under light 
microscopy. The stained structure in the micrographs 
Table 3 — Changes in % of cell viability of Vero-Cells with 
changes in biphasic HAP/ β-TCP coatings 
Concentration of  





% of Cell 
Viability 
5 1:1 0.12 30 
2.5 1:2 0.12 33 
1.25 1:4 0.21 56 
0.625 1:8 0.22 59 
0.3125 1:16 0.25 68 
0.156 1:32 0.29 77 
0.078 1:64 0.32 87 
0.039 1:12 0.33 90 




Fig. 5 — Cell cytotoxicity dose for HAP/β-TCP on 316 LSS at 





Fig. 6 — Cell viability in vero cells (A) normal Vero cell line 
(B) 50% cell viability with biphasic HAP/ β-TCP coated samples. 
Table 4 — Changes in % of cell viability of HEP II-Cells with 
changes in biphasic HAP/ β-TCP coatings 
Concentration of 
HAP/ β-TCP (µg) 
Dilution Optical Density 
(nm) 
% of Cell 
Viability 
5 1:1 0.18 27 
2.5 1:2 0.19 29 
1.25 1:4 0.21 32 
0.625 1:8 0.26 39 
0.3125 1:16 0.38 58 
0.156 1:32 0.45 68 
0.078 1:64 0.55 83 
0.039 1:12 0.56 85 
0 1:64 0.65 100 




indicates that the viable cells which are very less. 
Hence, the study suggests that more than 50% 
viability cannot be obtained while using the coated 
material as an implant device in cancerous cells. This 
study concludes that the implant device coated with 
HAP/β-TCP over 316L SS with 20V and 20 min 
duration of the substrate with a maximum of 5 g 
should show the biocompatibility with vero cells and 
not to the HEP II cells.  
 
DPPH assay 
Figure 9 shows DPPH activity of HAP/β-TCP on 
316L SS at 20V, 20 min after sintering. DPPH assay 
proves that the coated sample (at 20V, 20 min) has the 
antioxidant activity above 50% which is required for 
implants to be placed inside the biological medium. 
All values obtained are acquired from UV 
spectrophotometer for assays. 
 
% Anti-oxidant activity = {(absorbance at blank) – 




Fig. 9 — DPPH activity of HAP/β-TCP on 316 LSS at 20V & 20 
minutes, after sintering. 
 
From the above test it has been inferred that the 
sample traps the free radicals. 
 
Conclusion 
Biphasic coatings of HAP and β-TCP have been 
successfully coated on medical grade 316L SS 
electrophoretic deposition. No changes in crystalline 
structure and vibration properties have been observed 
before deposition and after sintering of the biphasic 
coatings. This biphasic coating are nontoxic which 
has been proved by the cytotoxicity test. The DPPH 
assay shows the antioxidant activity of the sample 
which proves that the sample traps the free radicals in 
the biological media. The study indicates that biphasic 
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